For the year ending 2025-12-31, AHCO had -$3,611K decrease in cash & cash equivalents over the period. $219,383K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -66,038 |
| Depreciation and amortization, including patient equipment depreciation | 381,927 |
| Goodwill impairment | 127,995 |
| Equity-based compensation | 21,876 |
| Change in fair value of warrant liability | 0 |
| Reduction in the carrying amount of operating lease right-of-use assets | 31,114 |
| Reduction in the carrying amount of finance lease right-of-use assets | 15,342 |
| Deferred income tax expense (benefit) | 47,163 |
| Change in fair value of interest rate swaps, net of reclassification adjustment | 0 |
| Amortization of deferred financing costs | 5,694 |
| Loss on extinguishment of debt | 0 |
| Payment of contingent consideration from an acquisition | 0 |
| Gain on sale of businesses (note 4) | 32,602 |
| Other | -2,721 |
| Accounts receivable | -30,986 |
| Inventory | 11,491 |
| Prepaid and other assets | 61,071 |
| Operating lease obligations | -31,117 |
| Operating liabilities | 139,272 |
| Net cash provided by operating activities | 601,771 |
| Purchases of equipment and other fixed assets | 382,388 |
| Payments for business acquisitions, net of cash acquired | 42,378 |
| Proceeds from the sale of businesses, net of cash disposed | 120,420 |
| Proceeds from the sale of assets | 0 |
| Payments for cost method investments | 0 |
| Receipt of contingent consideration from the sale of assets | 1,156 |
| Net cash used in investing activities | -303,190 |
| Repayments on long-term debt and lines of credit | 250,000 |
| Proceeds from borrowings on lines of credit | 0 |
| Repayments of finance lease obligations | 18,478 |
| Payments for shares purchased under share repurchase program | 0 |
| Proceeds from the exercise of stock options | 0 |
| Proceeds received in connection with employee stock purchase plan | 1,211 |
| Payments of debt financing costs | 25,045 |
| Distributions to noncontrolling interests | 6,967 |
| Payments for tax withholdings from vesting of restricted stock units | 2,701 |
| Payments of contingent consideration and deferred purchase price from acquisitions | 212 |
| Net cash used in financing activities | -302,192 |
| Net (decrease) increase in cash | -3,611 |
| Cash at beginning of period | 109,747 |
| Cash at end of period | 106,136 |
AdaptHealth Corp. (AHCO)
AdaptHealth Corp. (AHCO)